Guardant Health (GH) CIO granted 13,632 restricted stock units

Rhea-AI Filing Summary

Kalia Kumud reported acquisition or exercise transactions in this Form 4 filing.

Guardant Health, Inc. reported that Chief Information Officer Kalia Kumud received a grant of 13,632 restricted stock units (RSUs) on March 11, 2026. The award vests over three years: 33% on April 1, 2027, with the remaining 67% vesting in equal quarterly installments over the following two years. After this grant, Kumud holds 13,632 RSUs directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kalia Kumud

(Last) (First) (Middle)

3100 HANOVER STREET

(Street)

PALO ALTO CA 94304

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Information Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	03/11/2026		A		13,632		(1)	(2)	Common Stock	13,632	$0	13,632	D

Explanation of Responses:

1. This represents a restricted stock unit award granted on March 11, 2026 that vests over a three-year period. 33% of the shares subject to such award will vest on April 1, 2027 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

2. Not applicable for Restricted Stock Units.

Remarks:

	/s/ John G. Saia, as attorney-in-fact for Kumud Kalia	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Guardant Health (GH) disclose for Kalia Kumud?

Guardant Health disclosed that Chief Information Officer Kalia Kumud received a grant of 13,632 restricted stock units. These RSUs are a form of equity compensation that convert into common shares as they vest over time, aligning her interests with shareholders.

How many restricted stock units were granted to Guardant Health’s CIO?

The CIO of Guardant Health was granted 13,632 restricted stock units. This entire amount represents a new equity award, and all 13,632 units are reported as owned following the transaction, reflecting a compensation-related acquisition rather than an open-market share purchase.

What is the vesting schedule for the 13,632 RSUs at Guardant Health (GH)?

The 13,632 RSUs vest over three years. Footnotes state that 33% vest on April 1, 2027, while the remaining 67% vest in equal quarterly installments over the subsequent two years, creating a long-term incentive tied to continued employment.

Was the Guardant Health (GH) CIO’s Form 4 transaction a stock purchase or a grant?

The Form 4 reflects an equity grant, not a market purchase. It reports an “A” code transaction, meaning a grant, award, or other acquisition of 13,632 restricted stock units as part of compensation, with no cash price per share reported for the award.

Does the Guardant Health CIO hold the awarded RSUs directly or indirectly?

The filing shows the 13,632 restricted stock units are held directly. The ownership code is listed as direct, and there are no footnotes indicating that a trust, LLC, or other related entity holds the award on the CIO’s behalf.